Imax CEO Richard Gelfond is taking a short lived medial depart of absence as he undergoes therapy for pneumonia.
He won’t be taking part in any public or non-public occasions for the corporate, together with April’s business gathering CinemaCon in Las Vegas, whereas he receives medical care and recovers. The corporate issued an announcement to “present transparency and make sure that there isn’t a hypothesis arising out of his [absence],” including that “out of respect for Mr. Gelfond’s privateness as he’s being handled, Imax won’t present additional remark right now, however will present updates as acceptable.”
Throughout Gelfond’s absence, Imax’s senior workforce is executing their day-to-day duties in coordination with one another and board chair Darren Throop. They’re additionally in common communication with the total board of administrators. Among the many senior executives are Natasha Fernandes, govt VP and chief monetary officer; Anne Globe, chief advertising officer; Rob Lister, senior govt VP and chief authorized officer and Mark Welton, president of Imax Theatres.
“Now we have a robust, deeply skilled senior govt workforce who’re totally engaged, offering common updates to the board, and stay centered as all the time on the continued progress and success of Imax,” mentioned Throop. “We’re all wishing Wealthy nicely and a full and speedy restoration.”
Imax set a brand new file in 2025, grossing $1.2 billion on the international field workplace due to blockbusters like “F1,” “Avatar: Hearth and Ash” and “Sinners.” Trying forward, Imax is focusing on a much bigger benchmark of $1.4 billion in 2026 as tentpoles together with Christopher Nolan’s “The Odyssey,” Denis Villeneuve’s “Dune: Half Three” and “The Mandalorian and Grogu” gear up for launch.
